About Us | Contact Us
May 23, 2012 1:22 AM EDT
Updated: Aug 19, 2010 6:16 AM EDT  

Healthcare

Laux, Porter, Cavanaugh (212) 829-5484

News and Views

 

Business flows improved considerably as market was able to add small gains to yesterday’s advances. We had a lot of excellent two way situations, particularly in healthcare area – HNT,AMRN,ENDP,RSCR,FURX, and MEND. We even had a large cross in DPZ after being the axe on the buy side for a week(we’re still a large buyer in case your sales trader hasn’t told you).

 

Restaurants had a good day for the 3rd day in a row, led by DIN,PNRA,PFCB,BWLD,CMG. More red figures in small/midcap Biotechs than we’ve seen all week.

 

 

 HMO's up  slightly yesterday,  still  churning  after  sharp  selloff  last  week. Would look  for some  more  consolidation  before  another leg  down.   Big  Cap  Pharma  reaching  upper  end of  rising  channel  preparing to  complete  B wave of A-B-C  correction. Hospitals  continue to be a  source of  funds.


Macro/Technicals

XLV: 29.31; -.14
PPH: 61.85; -.31

Leaders: Leaders: KG+8.88%,ENDP+8.84%,DIN+5.03%,EAT+3.15%
Laggards: Laggards: MNKD-4.02%,ITMN-3.24%,ONXX-2.65%

Active Names

 

Active Names

Biotech/Pharma:  FURX ENDP AMRN KG

Healthcare Services:  MEND RSCR HNT HLS HUM LH PKI UNH UHS

Restaurants/Publishing/Retail:  DPZ SONC


Sector News, M&A, Capital Raises

CATM- 7mill secondary priced at 14

 

MNKD- 9 million secondary priced at 5.55, along with 100 million convert


Research Away

EW - initiated Buy at Madison Williams 

 

BMTI - initiated with Overweight at JPM


Cantor Flows

 

 

Biotech/Pharma:  FURX ENDP AMRN KG

Healthcare Services:  MEND RSCR HNT HLS HUM LH PKI UNH UHS

Restaurants/Publishing/Retail:  DPZ SONC


Disclaimer: Prepared by staff of Cantor Fitzgerald & Co. ("Cantor") and is for information purposes only. It is not intended to form the basis of any investment decision, should not be considered a recommendation by Cantor or any other person and does not constitute an offer or solicitation with respect to the purchase or sale of any investment nor is it a confirmation of terms. Any calculations and valuations presented herein are intended as a basis for discussion. Sources of information are believed to be reliable but Cantor makes no representation and gives no warranty that the information contained herein is accurate or complete. Any opinions or estimates given may change. Cantor undertakes no obligation to provide recipients with any additional information or any update to or correction of the information contained herein. This material is intended solely for institutional investors and investors who Cantor reasonably believes are institutional investors. Cantor, its officers, employees, affiliates and partners shall not be liable to any person in any way whatsoever for any losses, costs or claims howsoever arising from any inaccuracies or omissions in the information contained herein or any reliance on that information. Cantor may have positions in financial instruments mentioned, may have acquired such positions at prices no longer available, and may have interests different or adverse to your interests. No liability is accepted by Cantor for any loss that may arise from any use of the information contained herein or derived here from. This product may not be reproduced or redistributed outside the recipient's organization. Sources: Cantor Fitzgerald & Co., Reuters, Bloomberg, CNBC, Dow Jones, Marketwatch, Trade-Alert, and the Wall Street Journal. ***All eco data from Bloomberg and DJ